DiaMedica Therapeutics Announces $37.5 Million Private Placement
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases , today announced it has entered into... | June 21, 2023
Source: marketscreener.com